Among our merger and acquisition matters, we have represented:

• HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, in its management-led majority stake acquisition by a syndicate of globally recognized private and public investors including K5 Global, Bezos Expeditions and Wellington Management, and other new and existing investors. The transaction valued the company at $2.25 billion.
• preCardia, a privately held medical device company, in its sale to ABIOMED.
• BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a pharmaceutical company focused on reproductive health in the purchase of Cell Genesys, Inc. and a stock-for-stock merger with ANI Pharmaceuticals, including a Form S-4 registration statement in connection with the merger.
• CardioInsight, Inc., a medical device company specializing in cardiac mapping technology, in its sale to Medtronic, Inc. following Medtronic’s strategic investment in CardioInsight.
• Enantigen Therapeutics, Inc., a privately held pharmaceutical company located at the Pennsylvania Biotechnology Center, in its acquisition by OnCore Biopharma, Inc., a biotechnology company focused on the research, development and commercialization of oral treatments for chronic hepatitis B virus (HBV) infection.
• ev3 Inc. (NASDAQ: EVV), a global technology provider for specialists treating a wide range of vascular diseases and disorders, in its sale to Covidien for approximately $2.6 billion in cash, pursuant to a tender offer by Covidien.
• NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft-tissue microwave ablation systems, in the acquisition by Ethicon, a subsidiary of the Johnson & Johnson family of companies.
• ReShape Lifesciences, Inc., a company focused on the design, development and commercialization of transformative technologies to treat obesity and metabolic diseases, in its acquisition of multiple companies.
• RestorGenex Corporation (OTCQX: RESX), a public specialty biopharmaceutical company, in its merger with Diffusion Pharmaceuticals, a privately held clinical stage biotechnology company.
• Rotation Medical, Inc., a company with products to treat rotator cuff disease, in an acquisition by Smith & Nephew for $125 million in cash and up to $85 million in performance-based milestone payments.
• superDimension, a company that develops minimally invasive interventional pulmonology devices, in its sale to Covidien for approximately $350 million.
• Tornier N.V. (NASDAQ: TRNX), a premier high-growth extremities and biologics company, in its Stock-for-stock merger with Wright Medical Group, Inc., including a Form S-4 registration statement in connection with the merger. Acquisition of OrthoHelix Surgical Designs for approximately $135 million in a combination of cash and stock.
• Torax Medical, Inc., a company with products to treat gastro-esophageal reflux disease, in a sale to Ethicon, a subsidiary of the Johnson & Johnson family of companies.
• Vios Medical, Inc., a company developing a patient monitoring system, in its sale to Murata Manufacturing Co., Ltd.
• Virtual Radiologic Corporation (NASDAQ: VRAD), a global telemedicine company, in its sale to Providence Equity Partners for approximately $250 million.